
        <!DOCTYPE html>
        <html>
        <head>
            <meta charset="UTF-8">
            <meta name="viewport" content="width=device-width, initial-scale=1.0">
            <title>CASSIA Cell Type Annotation Summary (Breadth-First Analysis)</title>
            <style>
                :root {
                    --primary-color: #2563eb;
                    --secondary-color: #0891b2;
                    --accent-color: #4f46e5;
                    --light-bg: #f3f4f6;
                    --border-color: #e5e7eb;
                    --text-color: #1f2937;
                    --text-light: #6b7280;
                }
                
                body {
                    font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, sans-serif;
                    line-height: 1.6;
                    color: var(--text-color);
                    background-color: #ffffff;
                    margin: 0;
                    padding: 0;
                }
                
                .container {
                    max-width: 900px;
                    margin: 0 auto;
                    padding: 2rem;
                }
                
                header {
                    text-align: center;
                    margin-bottom: 2.5rem;
                    border-bottom: 2px solid var(--border-color);
                    padding-bottom: 1rem;
                }
                
                h1 {
                    color: var(--primary-color);
                    font-size: 2.5rem;
                    margin-bottom: 0.5rem;
                }
                
                .subtitle {
                    color: var(--text-light);
                    font-size: 1.2rem;
                    margin-top: 0;
                }
                
                section {
                    margin-bottom: 2.5rem;
                    background-color: white;
                    border-radius: 0.5rem;
                    box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
                    padding: 1.5rem;
                    border-left: 4px solid var(--primary-color);
                }
                
                h2 {
                    color: var(--primary-color);
                    font-size: 1.8rem;
                    margin-top: 0;
                    border-bottom: 1px solid var(--border-color);
                    padding-bottom: 0.5rem;
                }
                
                h3 {
                    color: var(--secondary-color);
                    font-size: 1.3rem;
                    margin: 1.5rem 0 0.5rem;
                }
                
                ul, ol {
                    padding-left: 1.5rem;
                }
                
                li {
                    margin-bottom: 0.5rem;
                }
                
                .final-annotation {
                    background-color: #ecfdf5;
                    border-left: 4px solid #10b981;
                }
                
                .final-annotation h2 {
                    color: #10b981;
                }
                
                .iteration {
                    margin-bottom: 1.5rem;
                    background-color: var(--light-bg);
                    border-radius: 0.5rem;
                    padding: 1.5rem;
                    border-left: 4px solid var(--secondary-color);
                }
                
                .iteration-title {
                    font-size: 1.5rem;
                    color: var(--secondary-color);
                    margin-top: 0;
                    border-bottom: 1px solid var(--border-color);
                    padding-bottom: 0.5rem;
                }
                
                .gene-list {
                    display: flex;
                    flex-wrap: wrap;
                    gap: 0.5rem;
                    margin: 1rem 0;
                }
                
                .gene-badge {
                    background-color: var(--accent-color);
                    color: white;
                    padding: 0.3rem 0.7rem;
                    border-radius: 1rem;
                    font-size: 0.9rem;
                    font-weight: 500;
                }
                
                .sub-section {
                    background-color: white;
                    border-radius: 0.3rem;
                    padding: 1rem;
                    margin-top: 1rem;
                }
                
                code {
                    font-family: ui-monospace, monospace;
                    font-size: 0.9em;
                }
                
                .marker-category {
                    margin-bottom: 1rem;
                }
                
                .marker-category-title {
                    font-weight: 600;
                    margin-bottom: 0.5rem;
                    color: var(--secondary-color);
                }
                
                .hypothesis-list {
                    display: flex;
                    flex-direction: column;
                    gap: 0.8rem;
                }
                
                .hypothesis-item {
                    padding-left: 1.5rem;
                    position: relative;
                    margin-bottom: 0.5rem;
                }
                
                .hypothesis-number {
                    position: absolute;
                    left: 0;
                    font-weight: 600;
                    color: var(--accent-color);
                }
                
                .hypothesis-item-continued {
                    padding-left: 1.5rem;
                    margin-top: -0.3rem;
                    color: var(--text-light);
                }

                /* Sidebar Navigation */
                .sidebar {
                    position: fixed;
                    top: 100px;
                    right: 20px;
                    width: 200px;
                    max-height: calc(100vh - 140px);
                    overflow-y: auto;
                    background: white;
                    border-radius: 8px;
                    box-shadow: 0 2px 8px rgba(0,0,0,0.1);
                    padding: 1rem;
                    z-index: 100;
                }

                .sidebar h4 {
                    font-size: 0.85rem;
                    color: var(--text-light);
                    margin: 0 0 0.75rem 0;
                    text-transform: uppercase;
                    letter-spacing: 0.05em;
                }

                .sidebar ul {
                    list-style: none;
                    padding: 0;
                    margin: 0;
                }

                .sidebar li {
                    margin-bottom: 0.4rem;
                }

                .sidebar a {
                    color: var(--text-color);
                    text-decoration: none;
                    font-size: 0.85rem;
                    display: block;
                    padding: 0.3rem 0.5rem;
                    border-radius: 4px;
                    transition: background-color 0.2s;
                }

                .sidebar a:hover {
                    background-color: var(--light-bg);
                    color: var(--primary-color);
                }

                .sidebar a.final {
                    color: #10b981;
                    font-weight: 600;
                }

                /* Adjust body for sidebar */
                @media (min-width: 1200px) {
                    body {
                        margin-right: 240px;
                    }
                }

                @media (max-width: 1199px) {
                    .sidebar {
                        display: none;
                    }
                }
            </style>
        </head>
        <body>
            <div class="container">
                <header>
                    <h1>CASSIA Cell Type Annotation Summary (Breadth-First Analysis)</h1>
                    <p class="subtitle">Single-cell RNA-seq Analysis Report</p>
                </header>
                
                <section id="overview">
                    <h2>Overview</h2>
                    <div class="content">
                        This report summarizes an iterative gene expression analysis performed by CASSIA to annotate a cell cluster. The analysis involved 3 iterations and examined a total of 29 unique genes.
                    </div>
                </section>

                <section id="initial-assessment">
                    <h2>Initial Assessment</h2>
                    <div class="content">
                        The initial cell type hypothesis was "Plasma Cell," strongly supported by robust expression of immunoglobulin genes and canonical plasma cell markers such as JCHAIN, TNFRSF17, and MZB1. The enrichment of IgA-related genes (IGHA1, IGHA2, JCHAIN) and CCR10 suggested IgA-secreting plasma cells, consistent with a large intestine origin. The presence of MYL2 was identified as an outlier requiring further investigation.
                    </div>
                </section>
        
                    <section id="iteration-1">
                        <h2>Iteration 1</h2>

                        <div class="sub-section">
                            <h3>Hypotheses</h3>
                            <div class="content">
                                <div class="hypothesis-list"><div class="hypothesis-item"><span class="hypothesis-number">1.</span> **Doublet with smooth muscle cell:** To investigate if the unexpected presence of MYL2 indicated a doublet event with a smooth muscle cell. This hypothesis predicted co-expression of other smooth muscle markers (ACTA2, MYH11) alongside plasma cell markers (SDC1) and negative markers for plasma cells (CD3E, CD19).</div><div class="hypothesis-item"><span class="hypothesis-number">2.</span> **Activated B cells / Plasmablasts:** To rule out a significant population of activated B cells or plasmablasts, which are precursors to plasma cells and share some gene expression. This hypothesis predicted mature plasma cells to have low or absent CD19 and MS4A1, while plasmablasts might retain these B cell markers along with PRDM1, XBP1, and SDC1.</div><div class="hypothesis-item"><span class="hypothesis-number">3.</span> **Contamination by other immune cells:** To rigorously confirm the purity of the plasma cell cluster by checking for markers of other common immune cell types. This hypothesis predicted that high expression of T-cell (CD3E), myeloid (CD14, FCGR3A, CD68), or mast cell (TPSAB1, CPA3) markers would indicate contamination.</div></div>
                            </div>
                        </div>

                        <div class="sub-section">
                            <h3>Genes Checked</h3>
                            <div class="gene-list"><span class="gene-badge">MYL2</span><span class="gene-badge">ACTA2</span><span class="gene-badge">MYH11</span><span class="gene-badge">CD3E</span><span class="gene-badge">CD19</span><span class="gene-badge">SDC1</span><span class="gene-badge">MS4A1</span><span class="gene-badge">CD27</span><span class="gene-badge">PRDM1</span><span class="gene-badge">XBP1</span><span class="gene-badge">CD14</span><span class="gene-badge">FCGR3A</span><span class="gene-badge">CD68</span><span class="gene-badge">TPSAB1</span><span class="gene-badge">CPA3</span></div>
                        </div>

                        <div class="sub-section">
                            <h3>Key Findings</h3>
                            <div class="content">
                                <div class="hypothesis-list"><div class="hypothesis-item"><span class="hypothesis-number">1.</span> Very high expression of MYL2 (avg_log2FC 8.15) with low detection (pct.1 0.12) suggested a minor but highly expressing contaminating population or specific doublet event. (Hypothesis_1)</div><div class="hypothesis-item"><span class="hypothesis-number">2.</span> High expression of CD14 (avg_log2FC 4.28, pct.1 0.25) indicated the presence of a myeloid contaminant. (Hypothesis_3)</div><div class="hypothesis-item"><span class="hypothesis-number">3.</span> Expression of CD27 (avg_log2FC 3.91, pct.1 0.81) and XBP1 (avg_log2FC 1.17, pct.1 0.94) was consistent with plasma cells or plasmablasts. (Hypothesis_2)</div><div class="hypothesis-item"><span class="hypothesis-number">4.</span> Low expression and detection rates of PRDM1 (avg_log2FC -3.32, pct.1 0.02) and SDC1 (avg_log2FC -2.76, pct.1 0.01) were concerning for a mature plasma cell annotation. (Hypothesis_2)</div><div class="hypothesis-item"><span class="hypothesis-number">5.</span> Absence of CD3E expression (avg_log2FC -5.41, pct.1 0.02) ruled out T-cell contamination. (Hypothesis_3)</div></div>
                            </div>
                        </div>
                    </section>
                
                    <section id="iteration-2">
                        <h2>Iteration 2</h2>

                        <div class="sub-section">
                            <h3>Hypotheses</h3>
                            <div class="content">
                                <div class="hypothesis-list"><div class="hypothesis-item"><span class="hypothesis-number">1.</span> **Myeloid Contamination / Doublets:** To further characterize the myeloid population suggested by CD14 expression. This hypothesis predicted that high expression of additional myeloid markers (FCGR3A, CD68, LYZ, S100A8, S100A9) would confirm and help quantify this contamination.</div><div class="hypothesis-item"><span class="hypothesis-number">2.</span> **Plasmablast vs. Mature Plasma Cell Re-evaluation:** To re-evaluate the maturity of the B-lineage cells given the low PRDM1 and SDC1 expression. This hypothesis predicted that high CD19 and MS4A1 would lean towards plasmablasts, while strong SDC1, PRDM1, IRF4, and TNFRSF17 would confirm mature plasma cells.</div><div class="hypothesis-item"><span class="hypothesis-number">3.</span> **MYL2-expressing cell type identification:** To confirm the identity of the MYL2-positive cells. This hypothesis predicted that co-expression of other smooth muscle markers (ACTA2, MYH11, DES, TAGLN, CALD1) would strongly support a smooth muscle cell contamination or doublet.</div></div>
                            </div>
                        </div>

                        <div class="sub-section">
                            <h3>Genes Checked</h3>
                            <div class="gene-list"><span class="gene-badge">CD14</span><span class="gene-badge">FCGR3A</span><span class="gene-badge">CD68</span><span class="gene-badge">LYZ</span><span class="gene-badge">S100A8</span><span class="gene-badge">S100A9</span><span class="gene-badge">CD19</span><span class="gene-badge">MS4A1</span><span class="gene-badge">SDC1</span><span class="gene-badge">PRDM1</span><span class="gene-badge">IRF4</span><span class="gene-badge">TNFRSF17</span><span class="gene-badge">MYL2</span><span class="gene-badge">ACTA2</span><span class="gene-badge">MYH11</span><span class="gene-badge">DES</span><span class="gene-badge">TAGLN</span><span class="gene-badge">CALD1</span></div>
                        </div>

                        <div class="sub-section">
                            <h3>Key Findings</h3>
                            <div class="content">
                                <div class="hypothesis-list"><div class="hypothesis-item"><span class="hypothesis-number">1.</span> Continued high expression of MYL2 (avg_log2FC 8.15) and new strong signal for CALD1 (avg_log2FC 1.60, pct.1 0.68) strongly suggested a significant smooth muscle cell component. (Hypothesis_3)</div><div class="hypothesis-item"><span class="hypothesis-number">2.</span> Persistent high CD14 (avg_log2FC 4.28) and new LYZ expression (avg_log2FC 1.71, pct.1 0.11) confirmed a myeloid component. (Hypothesis_1)</div><div class="hypothesis-item"><span class="hypothesis-number">3.</span> Very high expression of TNFRSF17 (avg_log2FC 8.84, pct.1 0.80), a key plasma cell marker, was observed. (Hypothesis_2)</div><div class="hypothesis-item"><span class="hypothesis-number">4.</span> Continued low expression and detection rates of PRDM1 (avg_log2FC -3.32, pct.1 0.02), SDC1 (avg_log2FC -2.76, pct.1 0.01), and IRF4 (avg_log2FC -3.84, pct.1 0.01) were problematic for a definitive mature plasma cell call. (Hypothesis_2)</div></div>
                            </div>
                        </div>
                    </section>
                
                    <section id="iteration-3">
                        <h2>Iteration 3</h2>

                        <div class="sub-section">
                            <h3>Hypotheses</h3>
                            <div class="content">
                                <div class="hypothesis-list"><div class="hypothesis-item"><span class="hypothesis-number">1.</span> **Mixed Population of Plasma Cells and Smooth Muscle Cells:** To assess if the distinct MYL2/CALD1 and TNFRSF17/JCHAIN signatures represented separate cell populations within the cluster. This hypothesis predicted that high expression of ACTA2 and MYH11 in MYL2/CALD1-positive cells would confirm smooth muscle cells, while high SDC1, TNFRSF17, and JCHAIN in cells lacking muscle markers would confirm plasma cells.</div><div class="hypothesis-item"><span class="hypothesis-number">2.</span> **Plasmablast vs. Early Plasma Cell vs. Mature Plasma Cell:** To precisely characterize the B-lineage cells given conflicting plasma cell marker signals. This hypothesis predicted that high CD19/MS4A1 with moderate CD27, PRDM1, IRF4, and XBP1 would suggest plasmablasts, while low CD19/MS4A1 and high CD27, PRDM1, IRF4, XBP1, and SDC1 would indicate mature plasma cells.</div><div class="hypothesis-item"><span class="hypothesis-number">3.</span> **Myeloid Cell Subtype Characterization:** To understand the nature of the persistent myeloid component. This hypothesis predicted that high expression of CD68, CD163, and MRC1 would point towards macrophages, while high S100A8 and S100A9 might suggest monocytes or neutrophils.</div></div>
                            </div>
                        </div>

                        <div class="sub-section">
                            <h3>Genes Checked</h3>
                            <div class="gene-list"><span class="gene-badge">MYL2</span><span class="gene-badge">CALD1</span><span class="gene-badge">ACTA2</span><span class="gene-badge">MYH11</span><span class="gene-badge">SDC1</span><span class="gene-badge">TNFRSF17</span><span class="gene-badge">JCHAIN</span><span class="gene-badge">CD19</span><span class="gene-badge">MS4A1</span><span class="gene-badge">CD27</span><span class="gene-badge">PRDM1</span><span class="gene-badge">IRF4</span><span class="gene-badge">XBP1</span><span class="gene-badge">CD14</span><span class="gene-badge">LYZ</span><span class="gene-badge">CD68</span><span class="gene-badge">FCGR3A</span><span class="gene-badge">CD163</span><span class="gene-badge">MRC1</span><span class="gene-badge">S100A8</span></div>
                        </div>

                        <div class="sub-section">
                            <h3>Key Findings</h3>
                            <div class="content">
                                <div class="hypothesis-list"><div class="hypothesis-item"><span class="hypothesis-number">1.</span> The very high expression of JCHAIN (avg_log2FC 9.82, pct.1 0.99), TNFRSF17 (avg_log2FC 8.84, pct.1 0.80), CD27 (avg_log2FC 3.91, pct.1 0.81), and XBP1 (avg_log2FC 1.17, pct.1 0.94) firmly established the presence of a B-lineage population undergoing plasma cell differentiation. (Hypothesis_2)</div><div class="hypothesis-item"><span class="hypothesis-number">2.</span> The persistent low expression of PRDM1 (avg_log2FC -3.32, pct.1 0.02), IRF4 (avg_log2FC -3.84, pct.1 0.01), and SDC1 (avg_log2FC -2.76, pct.1 0.01) suggested the B-lineage population might be enriched for plasmablasts or early plasma cells rather than fully mature plasma cells. (Hypothesis_2)</div><div class="hypothesis-item"><span class="hypothesis-number">3.</span> High expression of MYL2 (avg_log2FC 8.15) and CALD1 (avg_log2FC 1.60, pct.1 0.68) unequivocally indicated a smooth muscle cell presence. (Hypothesis_1)</div><div class="hypothesis-item"><span class="hypothesis-number">4.</span> Continued detection of CD14 (avg_log2FC 4.28) and LYZ (avg_log2FC 1.71, pct.1 0.11) confirmed a minor myeloid component. (Hypothesis_3)</div></div>
                            </div>
                        </div>
                    </section>
                
                <section id="final-annotation" class="final-annotation">
                    <h2>Final Annotation</h2>
                    <div class="content">
                        The final cell type is **IgA-secreting Plasmablasts/Early Plasma Cells with Smooth Muscle Cell and Myeloid Contamination**.
Confidence level: **Medium**
Main supporting evidence: The presence of a B-lineage population undergoing plasma cell differentiation is strongly supported by high expression of JCHAIN, TNFRSF17, CD27, and XBP1. However, the consistently low expression of PRDM1, IRF4, and SDC1 suggests an earlier differentiation stage (plasmablasts or early plasma cells). Significant contamination is indicated by high MYL2 and CALD1 for smooth muscle cells, and CD14 and LYZ for myeloid cells.
                    </div>
                </section>
        
                    <section id="marker-genes">
                        <h2>Key Marker Genes</h2>
                        <div class="content">
                            **B-lineage (Plasmablast/Early Plasma Cell):**
*   **Differentiation/Function:** JCHAIN (IgA secretion), TNFRSF17 (BCMA, plasma cell marker), CD27 (B cell memory/plasma cell marker), XBP1 (plasma cell differentiation transcription factor).
*   **Low/Absent (suggesting earlier stage):** PRDM1 (Blimp-1, mature plasma cell transcription factor), IRF4 (plasma cell differentiation), SDC1 (CD138, mature plasma cell marker).

**Contaminating Populations:**
*   **Smooth Muscle Cells:** MYL2, CALD1.
*   **Myeloid Cells:** CD14, LYZ.
                        </div>
                    </section>
                
                    <section id="recommendations">
                        <h2>Recommendations</h2>
                        <div class="content">
                            The user should next perform sub-clustering of this identified cluster to computationally separate the distinct cell populations (B-lineage, smooth muscle, and myeloid cells) based on their unique marker profiles. This would allow for a more precise annotation of the B-lineage component and the removal or separate annotation of the contaminating cells.
                        </div>
                    </section>
                
            </div>
            
            <nav class="sidebar">
                <h4>Contents</h4>
                <ul>
                    <li><a href="#overview">Overview</a></li><li><a href="#initial-assessment">Initial Assessment</a></li><li><a href="#iteration-1">Iteration 1</a></li><li><a href="#iteration-2">Iteration 2</a></li><li><a href="#iteration-3">Iteration 3</a></li><li><a href="#final-annotation" class="final">Final Annotation</a></li><li><a href="#marker-genes">Key Marker Genes</a></li><li><a href="#recommendations">Recommendations</a></li>
                </ul>
            </nav>
        
            
            <script>
                document.querySelectorAll('.sidebar a').forEach(link => {
                    link.addEventListener('click', function(e) {
                        e.preventDefault();
                        const target = document.querySelector(this.getAttribute('href'));
                        if (target) {
                            target.scrollIntoView({ behavior: 'smooth', block: 'start' });
                        }
                    });
                });
            </script>
        
        </body>
        </html>
        